Most cited papers from Oncode Institute
What are the most cited papers from Oncode Institute?
The most cited paper from Oncode Institute is "Signatures of mutational processes in human cancer" (Australian Pancreatic Cancer Genome Initiative et al., 2013), with 10,284 citations. Next come "Gene expression profiling predicts clinical outcome of breast cancer" (9,661) and "Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer" (8,049).
Showing 50 of 60 papers. Every paper with more than 1,229 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Signatures of mutational processes in human cancer Australian Pancreatic Cancer Genome Initiative et al. · Nature | 14 Aug 2013 | 10,284 |
| 2 | Gene expression profiling predicts clinical outcome of breast cancer Laura van ‘t Veer, Hongyue A. Dai, Marc J. van de Vijver et al. · Nature | 2002 | 9,661 |
| 3 | Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer Naiyer A. Rizvi et al. · Science | 12 Mar 2015 | 8,049 |
| 4 | Computational Radiomics System to Decode the Radiographic Phenotype Joost J. M. van Griethuysen, Andriy Fedorov, Chintan Parmar et al. · Cancer Research | 31 Oct 2017 | 6,776 |
| 5 | A Gene-Expression Signature as a Predictor of Survival in Breast Cancer Marc J. van de Vijver et al. · New England Journal of Medicine | 18 Dec 2002 | 6,562 |
| 6 | A System for Stable Expression of Short Interfering RNAs in Mammalian Cells Thijn R. Brummelkamp, René Bernards, Reuven Agami · Science | 19 Apr 2002 | 4,319 |
| 7 | The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth Karin E. de Visser, Johanna A. Joyce · Cancer Cell | Mar 2023 | 4,002 |
| 8 | The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature | 5 Feb 2020 | 3,854 |
| 9 | Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature | 5 Feb 2020 | 3,360 |
| 10 | Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma Jesse Meir Zaretsky et al. · New England Journal of Medicine | 13 Jul 2016 | 3,284 |
| 11 | Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers Karoline B. Kuchenbaecker et al. · JAMA | 20 Jun 2017 | 2,963 |
| 12 | B cells and tertiary lymphoid structures promote immunotherapy response Beth Ann Helmink et al. · Nature | 15 Jan 2020 | 2,809 |
| 13 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy | 2 Jan 2021 | 2,743 |
| 14 | The human tumor microbiome is composed of tumor type–specific intracellular bacteria Deborah Nejman et al. · Science | 28 May 2020 | 2,523 |
| 15 | The Human Cell Atlas Aviv Regev et al. · eLife | 5 Dec 2017 | 2,441 |
| 16 | International network of cancer genome projects Jennifer L. Jennings et al. · Nature | 13 Apr 2010 | 2,439 |
| 17 | Landscape of somatic mutations in 560 breast cancer whole-genome sequences Serena Nik‐Zainal et al. · Nature | 29 Apr 2016 | 2,395 |
| 18 | Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression Urmo Võsa et al. · Nature Genetics | Sep 2021 | 2,339 |
| 19 | A Landscape of Pharmacogenomic Interactions in Cancer Francesco Iorio et al. · Cell | Jul 2016 | 2,333 |
| 20 | Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs Alfred H. Schinkel, Jasper Smit, Olaf van Tellingen et al. · Cell | May 1994 | 2,298 |
| 21 | Regulation and Function of the PD-L1 Checkpoint Chong Sun, Riccardo Mezzadra, Ton N. Schumacher · Immunity | Mar 2018 | 2,294 |
| 22 | Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes Australian Pancreatic Cancer Genome Initiative et al. · Nature | 24 Oct 2012 | 2,133 |
| 23 | Towards a systems understanding of MHC class I and MHC class II antigen presentation Jacques Neefjes, Marlieke L.M. Jongsma, Petra Paul et al. · Nature reviews. Immunology | 11 Nov 2011 | 2,069 |
| 24 | A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity Norman Sachs et al. · Cell | 7 Dec 2017 | 2,061 |
| 25 | The essence of senescence: Figure 1. Thomas Kuilman, Chrysiis Michaloglou, Wolter J. Mooi et al. · Genes & Development | 15 Nov 2010 | 2,051 |
| 26 | The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells Marc van de Wetering, Elena Lanchares Sancho, Cornelis L. Verweij et al. · Cell | Oct 2002 | 2,026 |
| 27 | Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens Matthew M. Gubin et al. · Nature | 25 Nov 2014 | 2,015 |
| 28 | Neutrophils in cancer: neutral no more Seth B. Coffelt, Max D. Wellenstein, Karin E. de Visser · Nature reviews. Cancer | 10 Jun 2016 | 1,895 |
| 29 | A Genomic and Functional Inventory of Deubiquitinating Enzymes Sebastian M. B. Nijman, Mark P.A. Luna‐Vargas, Arno Velds et al. · Cell | Dec 2005 | 1,866 |
| 30 | Organoids in cancer research Jarno Drost, Hans C. Clevers · Nature reviews. Cancer | 24 Apr 2018 | 1,820 |
| 31 | Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research Manuel M. Hidalgo, Frédéric Amant, Andrew Victor Biankin et al. · Cancer Discovery | 16 Jul 2014 | 1,810 |
| 32 | A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins Piet Borst, Raymond Evers, Marcel Kool et al. · JNCI Journal of the National Cancer Institute | 16 Aug 2000 | 1,766 |
| 33 | IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis Seth B. Coffelt, Kelly Kersten, Chris W. Doornebal et al. · Nature | 30 Mar 2015 | 1,746 |
| 34 | Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy Eric A. Reits, James W. Hodge, Carla A. Herberts et al. · The Journal of Experimental Medicine | 24 Apr 2006 | 1,744 |
| 35 | Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial Renu R. Bahadoer et al. · The Lancet Oncology | 7 Dec 2020 | 1,715 |
| 36 | Epidemiology of Renal Cell Carcinoma Umberto Capitanio, Karim Bensalah, Axel Bex et al. · European Urology | 20 Sep 2018 | 1,699 |
| 37 | SARS-CoV-2 productively infects human gut enterocytes Mart Matthias Lamers et al. · Science | May 2020 | 1,688 |
| 38 | Defining ‘T cell exhaustion’ Christian U. Blank, W. Nicholas Haining, Werner Held et al. · Nature reviews. Immunology | 30 Sep 2019 | 1,669 |
| 39 | Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7 Gerrit G. Langer, Serge X. Cohen, Victor S. Lamzin et al. · Nature Protocols | 19 Jun 2008 | 1,651 |
| 40 | CD8+ T cell states in human cancer: insights from single-cell analysis Anne M. van der Leun, Daniela S. Thommen, Ton N. Schumacher · Nature reviews. Cancer | 5 Feb 2020 | 1,602 |
| 41 | Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis Sónia A. Melo, Hikaru Sugimoto, Joyce T. O’Connell et al. · Cancer Cell | 24 Oct 2014 | 1,590 |
| 42 | Therapeutic cancer vaccines Mansi Saxena, Sjoerd H. van der Burg, Cornelis J.M. Melief et al. · Nature reviews. Cancer | 27 Apr 2021 | 1,589 |
| 43 | Mammalian ABC Transporters in Health and Disease Piet Borst, R. Oude Elferink · Annual Review of Biochemistry | Jun 2002 | 1,585 |
| 44 | The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus Jacqueline J.L. Jacobs, Karin Kieboom, Silvia Marino et al. · Nature | 1999 | 1,583 |
| 45 | Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress Geert J.P.L. Kops, Tobias B. Dansen, Paulien E. Polderman et al. · Nature | Sep 2002 | 1,579 |
| 46 | Genome-wide cell-free DNA fragmentation in patients with cancer Stephen Cristiano et al. · Nature | 29 May 2019 | 1,561 |
| 47 | Eleven grand challenges in single-cell data science David Lähnemann et al. · Genome biology | 7 Feb 2020 | 1,493 |
| 48 | Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease Jasper Smit, Alfred H. Schinkel, Ronald P.J. Oude Elferink et al. · Cell | Nov 1993 | 1,478 |
| 49 | Molecular Reconstruction of Sleeping Beauty, a Tc1-like Transposon from Fish, and Its Transposition in Human Cells Zoltán Ivics, Perry B. Hackett, Ronald H.A. Plasterk et al. · Cell | Nov 1997 | 1,446 |
| 50 | Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers Myriam Chalabi et al. · Nature Medicine | Apr 2020 | 1,437 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.